Selected article for: "cardiovascular disease and respiratory system"

Author: Li, Mingzhe; Chen, Siyang; Xiang, Xiaochen; Wang, Qiang; Liu, Xiaoliu
Title: Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system
  • Cord-id: ngwnzmrk
  • Document date: 2020_10_6
  • ID: ngwnzmrk
    Snippet: The clinical manifestations of COVID-19 are mainly respiratory symptoms, but some patients present with cardiovascular system disease such as palpitations and shortness of breath as the first or secondary symptoms. In this paper, we describe the characteristics of SARS-CoV‑2 and its functional receptor angiotensin-converting enzyme 2 (ACE2). Furthermore, we explore the impact of virus-induced myocardial damage, decreased ACE2 activity, immune imbalance, hypoxemia, and heart damage caused by an
    Document: The clinical manifestations of COVID-19 are mainly respiratory symptoms, but some patients present with cardiovascular system disease such as palpitations and shortness of breath as the first or secondary symptoms. In this paper, we describe the characteristics of SARS-CoV‑2 and its functional receptor angiotensin-converting enzyme 2 (ACE2). Furthermore, we explore the impact of virus-induced myocardial damage, decreased ACE2 activity, immune imbalance, hypoxemia, and heart damage caused by antiviral drugs.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • acute ards respiratory distress syndrome and low respiratory tract: 1, 2
    • acute ards respiratory distress syndrome and lung heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
    • acute ards respiratory distress syndrome and lung injury degree: 1, 2, 3
    • acute ards respiratory distress syndrome and lung protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute ards respiratory distress syndrome and lung protective effect: 1, 2
    • acute ards respiratory distress syndrome and macrophage specific: 1, 2
    • acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome cause and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute ards respiratory distress syndrome cause and lung protection: 1
    • acute ards respiratory distress syndrome cause and magnetic resonance: 1
    • acute coronary syndrome and lung injury: 1
    • acute coronary syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute myocardial injury and lung heart: 1, 2
    • acute myocardial injury and lung injury: 1, 2, 3, 4
    • acute myocardial injury and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute myocarditis and lung heart: 1, 2, 3, 4, 5, 6, 7
    • acute myocarditis and lung injury: 1, 2, 3, 4, 5, 6, 7